Related Experiment Video
Updated: May 5, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
A Systematic Review of Pediatric Acute Generalized Exanthematous Pustulosis
Ying Shan Cheung1, An Jian Leung1, Meiqi May Liau2
1Department of Medicine, National University Hospital, Singapore, Singapore.
Abstract:
Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse reaction in children. In this systematic review of 47 cases, a male predominance was observed, and medications remained the most common trigger for AGEP, with a higher contribution from infectious etiologies compared with frequencies reported in adult studies. Management primarily involved cessation of the inciting drug, topical corticosteroids, and supportive care. These findings provide practical guidance for early recognition and evaluation of pediatric AGEP.
Insights
Acute generalized exanthematous pustulosis (AGEP) in children is rare and severe. Medications commonly trigger AGEP in kids, with infections playing a larger role than in adults, guiding pediatric recognition and management.
Area of Science:
- Dermatology
- Pediatrics
- Pharmacovigilance
Background:
- Acute generalized exanthematous pustulosis (AGEP) is a rare but severe cutaneous adverse drug reaction.
- Pediatric AGEP is less understood than adult cases, necessitating specific research.
- Identifying triggers and effective management is crucial for improving outcomes in children.
Purpose of the Study:
- To systematically review cases of pediatric AGEP.
- To identify common triggers, clinical characteristics, and management strategies for AGEP in children.
- To provide data for early recognition and evaluation of pediatric AGEP.
Main Methods:
- Systematic review of 47 reported cases of pediatric AGEP.
- Analysis of patient demographics, causative agents, clinical presentation, and treatment outcomes.
- Comparison of findings with existing literature on adult AGEP.
Main Results:
- A male predominance was observed in pediatric AGEP cases.
- Medications were the most frequent trigger, with infectious etiologies contributing more significantly than in adults.
- Primary management involved drug cessation, topical corticosteroids, and supportive care.
Conclusions:
- Medications and infections are key triggers for pediatric AGEP.
- Effective management includes drug withdrawal, topical steroids, and supportive measures.
- Findings offer practical guidance for the clinical evaluation and management of children with AGEP.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acne Infection

